Skip to main content
Livermore
Livermore
ZHEN

Aurinia Pharmaceuticals Inc.

AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001600620

In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Aurinia Pharmaceuticals Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of AUPH: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders1861200+15
Shares50.5M36.2K50.3M−145.0K (−0.3%)
Value$553.5M$396.7K$487.5M−$65.6M (−11.9%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to AUPH in Q2 2023
InstitutionSharesValue% of portfolio
TIG Advisors, LLC561,096$5.43M0.33%
J. Goldman & Co LP552,407$5.35M0.31%
Antara Capital LP500,000$4.84M5.98%
Prudential Financial Inc241,740$2.34M0.00%
Nordea Investment Management AB212,400$2.12M0.00%
Gsa Capital Partners LLP168,595$1.63M0.16%
Brookfield Asset Management Inc.150,633$1.46M0.01%
Tang Capital Management LLC150,000$1.45M0.21%
Jupiter Asset Management Ltd98,690$955.3K0.01%
Franklin Resources Inc88,264$854.4K0.00%
Fox Run Management, L.L.C.53,827$521.0K0.15%
Ensign Peak Advisors, Inc35,450$343.2K0.00%
Moran Wealth Management, LLC29,962$290.0K0.01%
Aigen Investment Management, LP29,675$287.3K0.04%
NinePointTwo Capital25,804$249.0K0.10%
Two Sigma Securities, LLC23,967$232.0K0.02%
Lazard Asset Management LLC23,291$224.0K0.00%
Axq Capital, LP19,100$184.9K0.23%
Engineers Gate Manager LP16,769$162.3K0.01%
Seven Eight Capital, LP15,983$154.7K0.03%
Virtu Financial LLC15,795$153.0K0.01%
Skandinaviska Enskilda Banken AB (publ)14,400$139.0K0.00%
XTX Topco Ltd13,561$131.3K0.02%
Wolverine Trading, LLC13,220$121.1K0.00%
BCS Wealth Management12,170$118.0K0.09%
Daymark Wealth Partners, LLC10,000$96.8K0.01%
Focused Wealth Management, Inc5,000$48.4K0.01%
Macquarie Group Ltd1,473$14.3K0.00%
Fiduciary Alliance LLC1,000$9.68K0.00%
RFP Financial Group LLC1,000$9.68K0.00%
Centiva Capital, LP316$3.06K0.00%
Moser Wealth Advisors, LLC200$1.94K0.00%
Spotlight Asset Group, Inc.75$7260.00%

Sold out (18)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of AUPH in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Walleye Trading LLC129,080$1.41M
Tudor Investment Corp Et Al105,952$1.16M
EAM Investors, LLC82,453$903.7K
AWM Investment Company, Inc.73,500$805.6K
Innovis Asset Management LLC27,410$300.4K
Bayesian Capital Management, LP22,000$241.1K
Gladstone Institutional Advisory LLC17,300$189.6K
Quantamental Technologies LLC14,469$158.6K
Aquatic Capital Management LLC13,200$145.0K
XR Securities LLC12,000$131.5K
Y-Intercept (Hong Kong) Ltd10,586$116.0K
Belvedere Trading LLC8,740$95.8K
Northwestern Mutual Wealth Management Co2,500$27.4K
Accel Wealth Management1,045$11.5K
Steward Financial Group LLC1,000$10.0K
Savior LLC801$8.78K
Belpointe Asset Management LLC221$2.42K
Ellevest, Inc.2$22

Not filed for Q2 2023 yet (1)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AUPH in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Kula Investments, LLC36,199$396.7K